Borneol gout gel

A technology of gel and borneol, applied in the field of medicine, can solve the problems of high recurrence rate, large economic burden on patients, large renal toxicity and side effects, etc., and achieve the effects of reducing toxic side effects, reducing adverse reactions, and improving medication compliance.

Pending Publication Date: 2022-01-14
凯乐康医药科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, although Western medicine can quickly relieve symptoms, the recurrence rate is high, and it will rebound after stopping the drug. It must be taken contin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0016] The embodiments of the present application will be described in detail with the following examples, so that the implementation process of how to apply technical means to solve technical problems and achieve technical effects in the present application can be fully understood and implemented accordingly.

[0017] A borneol gout gel, the gel is prepared from raw materials and auxiliary materials, and the raw materials are proportioned according to the following weights: Polygonum cuspidatum 80-140 g, plantain 80-100 g, honeycomb 30-40 g, natural borneol 3 g -5g, Shengnanxing 10-20g, Mint 60-90g, Panax notoginseng 20-100g, Jinjia 20-100g, Yanhu 10-50g, Musk 30-40g, Alisma 3-150g, Achyranthes sichuanensis 4-210g, Fangji 5-130g, hawthorn 10-20g, seaweed 5-10g, geranium 40-50g, see blood fly 20-40g; the proportion of excipients is as follows: borneol liquid 90-120g, medicinal rice wine 400- 500g; the ratio of borneol liquid and medicinal rice wine is 1:5.

[0018] In the emb...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses borneol gout gel. The borneol gout gel is prepared from bulk drugs and auxiliary drugs. The bulk drugs comprise the following components by weight: 80-140 g of giant knotweed rhizome, 80-100 g of plantain herb, 30-40 g of honeycomb, 3-5 g of natural borneol, 10-20 g of raw arisaema heterophyllum blume, 60-90 g of mint, 20-100 g of pseudo-ginseng, 20-100 g of golden nail, 10-50 g of corydalis tuber, 30-40 g of musk, 3-150 g of rhizoma alismatis, 4-210 g of medicinal cyathula root, 5-130 g of stephania tetrandra, 10-20 g of hawthorn, 5-10 g of seaweed, 40-50 g of geranium wilfordii, and 20-40 g of caesalpinia cucullata. Compared with a current chemical treatment medicine, the gel prepared by the invention is an external medicine, has the advantages of obviously reduced adverse reaction and toxic and side effects, good permeability, capability of directly reaching an affected part, anti-inflammation and analgesia, obvious treatment effect, and obviously improved medication compliance of a patient with gouty arthritis, and the living quality of the patient is improved. The gel disclosed by the invention contains a plurality of medicine components, effectively solves the root cause of gouty arthritis, and has the effect of treating both symptoms and root causes on the treatment effect of gouty arthritis.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a borneol gout gel. Background technique [0002] At present, colchicine is the most commonly used drug for the treatment of gouty arthritis. In addition, phenylbutazone or indomethacin can still be used. If the serum uric acid continues to rise, carboxybenzsulfonamide can also be used, which plays a therapeutic role by inhibiting the reabsorption of urate by the renal tubules, and is one of the effective therapeutic drugs. If renal disease is present, allopurines are usually the treatment of choice. In the acute phase, intra-articular steroid injections, joint immobilization and local cold compresses can significantly reduce symptoms. However, although Western medicine can quickly relieve symptoms, the recurrence rate is high, and it will rebound after stopping the drug. It must be taken continuously for a long time, which brings a large economic burden to the patient, and th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8884A61K9/06A61P19/06A61P19/02A61P29/00A61K31/045A61K35/36A61K35/55A61K35/64
CPCA61K36/704A61K36/68A61K35/64A61K31/045A61K36/8884A61K36/534A61K36/258A61K35/36A61K36/66A61K35/55A61K36/884A61K36/21A61K36/59A61K36/734A61K36/02A61K36/185A61K36/758A61K9/06A61K9/0014A61P19/06A61P19/02A61P29/00A61K2236/331A61K2236/53A61K2236/15A61K2300/00
Inventor 蔡庆财
Owner 凯乐康医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products